Search

everythinglearnresearchcommunity

for

Search:↓

Hair restoration surgery can lead to serious complications like blood clots.

Injecting Platelet-Rich Plasma reduces leakage risk in colorectal surgery.

Anti-angiogenic therapy can help treat cancer but may cause resistance and side effects, so alternative methods are being explored.

Poly-L-lactic acid injections can cause hair loss and skin issues.

PRP therapy may cause infections and other issues, needing more research for safety.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.

A 77-year-old woman with hair loss had high testosterone and 17OH-progesterone levels, but no significant findings on imaging.

Scalp cooling is recommended to prevent chemotherapy-induced hair loss, but no effective drugs are available.

Accurate diagnosis and tailored treatment are crucial for managing common primary care symptoms.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.

PLLA injections can cause hair loss and skin issues.

miR-150 helps blood vessel cells develop and speeds up blood clot healing.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.

Alopecia areata patients have a higher risk of blood clots.

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Wnt signaling is vital for cell growth, development, and cancer research.

Off-pump heart surgery reduces complications without affecting survival rates compared to on-pump surgery.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Improving artificial vascular grafts requires better materials and surface designs to reduce blood clotting and support blood vessel cell growth.